论文部分内容阅读
目的:观察安胃汤与泮托拉唑治疗合并幽门螺旋杆菌(HP)感染胃溃疡的临床效果。方法:选取2014年5月~2015年10月我院收治的合并幽门螺旋杆菌感染胃溃疡患者120例,对照组60例采用阿莫西林+克拉霉素+泮托拉唑根治HP三联疗法进行治疗,观察组60例采用安胃汤+泮托拉唑进行治疗,观察治疗后HP根治情况,并对两组的临床疗效进行比较。结果:观察组治疗后HP转阴率为63.33%,明显高于对照组HP转阴率38.33%,比较具有统计学意义(P<0.05);观察组治疗总有效率为95%,明显高于对照组总有效率75%,比较具有统计学意义(P<0.05)。结论:安胃汤与泮托拉唑治疗合并幽门螺旋杆菌感染胃溃疡的临床效果显著,HP转阴率高,值得临床应用与推广。
Objective: To observe the clinical efficacy of AnWei Decoction and Pantoprazole in treating gastric ulcer with Helicobacter pylori infection. Methods: From May 2014 to October 2015, 120 patients with gastric ulcer complicated by Helicobacter pylori in our hospital were treated with amoxicillin + clarithromycin + pantoprazole and HP triple therapy in the control group , 60 cases in observation group were treated with AnWeitang + Pantoprazole, the cure of HP after treatment was observed, and the clinical curative effect was compared between the two groups. Results: After treatment, the negative conversion rate of HP in the observation group was 63.33%, which was significantly higher than that in the control group (38.33%), with a statistically significant difference (P <0.05). The total effective rate in the observation group was 95% The total effective rate was 75% in the control group, with statistical significance (P <0.05). Conclusion: Anwei Decoction and pantoprazole combined treatment of gastric ulcer caused by Helicobacter pylori clinical effect is significant, HP negative conversion rate, worthy of clinical application and promotion.